Among the identified glycopeptides, the intensity of HAN253WTLTPLK (H5N4S2) and (H5N4S1) was significantly increased in AFP-negative HCC patients (Figure 4C, detailed information shown in Supplementary Table S4), which was partially consistent with the result of label-free. The gene discussed is AFP; the disease is hepatocellular carcinoma.